期刊文献+

HBV相关肝细胞癌综合治疗中抗病毒的作用

Role of Antiviral Treatment in the Patients with HBV Related Hepatocellular Carcinoma
下载PDF
导出
摘要 分析抗病毒治疗在乙型肝炎病毒相关肝细胞癌的综合治疗中所起的作用。随着肝细胞癌治疗模式的转变,目前认为抗HBV治疗是HCC综合治疗的重要组成部分,应针对患者进行个体化、优化的多学科综合治疗,选择合适的高效、低耐药、低副作用的抗病毒药物,才能达到提高患者生活质量和延长生存时间的目的。 To review the current situation of antiviral treatment in the patients with HBV related hepatoeellular carcinoma. As the change of treatment mode in the patients with HBV related hepatoeellular carcinoma, it is universally acknowledged that anti-- HBV treatment is very important part of combined therapy for HCC. Individualized and optimal multiple modai- ity therapy should be selected to treat these patients with HBV related HCC. Anti--HBV drug with high efficiency, low resistance and low adverse drug reactions should be selected. Thus patients" quality of life would be improved and the survival time would be prolonged.
出处 《医学与哲学(B)》 2012年第1期34-35,47,共3页 Medicine & Philosophy(B)
关键词 乙型肝炎病毒 肝细胞癌 抗病毒治疗 hepatitis B virus, hepatocellular carcinoma, antiviral treatment
  • 相关文献

参考文献18

  • 1Jemal A, Center M M, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends[J]. Cancer Epidemiol Bio- markers Prey,2010,19(8) :1893--1907.
  • 2杨秉辉,丛文铭,周晓军,陈孝平,杨甲梅,樊嘉,王建华,杨仁杰,李槐,蒋国梁,曾昭冲,陈敏华,陈敏山,梁萍,吕明德,罗荣城,刘鲁明,秦叔逵,叶胜龙.原发性肝癌规范化诊治的专家共识[J].实用肝脏病杂志,2009,12(5):321-328. 被引量:72
  • 3Chen C J, Yang H I, Su J, et al. Risk of hepatoeellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J]. JAMA,2006,295(1):65--73.
  • 4Shamliyan T A, MacDonald R, Shaukat A, et al. Antiviral thera- py for adults with chronic hepatitis B: a systematic review for a Na- tional Institutes of Health Consensus Development Conference[J]. Ann Intern Med, 2009,150(2) .. 111-- 124.
  • 5Sung J J, Tsoi K K, Wong V W, et al. Meta--analysis: Treat- ment of hepatitis B infection reduces risk of hepatocellular carcino- ma[J]. Aliment Pharmacol Ther, 2008,28(9) : 1067-- 1077.
  • 6Yu M W, Yeh S H, Chen P J, et al. Hepatitis B virus genotype and DNA levels and hepatoeellular carcinoma: a prospective study in men[J]. J Natl Cancer Inst,2005,97(4):265--272.
  • 7Tasci I, Mas M R, Vural S A, et al. Rat liver fibrosis regresses better with pegylated interferon alpha--2b and ursodeoxycholic acid treatment than spontaneously recovery[J]. Liver Int, 2006,26 (2) : 261--268.
  • 8Li N, Lai E C, Shi J, et aI. A comparative study of antiviral thera- py after resection of hepatocellular carcinoma in the immune--ac- tive phase of hepatitis B virus infection[J]. Ann Surg Oncol,2010, 17(1) ..179--185.
  • 9Singal A K, Freeman D H Jr, Anand B S. Meta--analysis: inter- feron improves outcomes following ablation or resection of hepato- cellular careinoma[J]. Aliment Pharmacol Ther, 2010,32 (7), 851 --858.
  • 10Mazzaferro V, Romito R, Schiavo M, et al. Prevention of hepato- cellular carcinoma recurrence with alpha--interferon after liver re- section in HCV cirrhosis [J]. Hepatology, 2006, 44 (6) : 1543 -- 1554.

二级参考文献7

共引文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部